Newsroom

Aerial view of the Science Campus Braunschweig-Süd; in the foreground on the left is the building where AveThera GmbH will carry out GMP manufacturing

News

The Helmholtz Centre for Infection Research (HZI) welcomes the acquisition of the Braunschweig site of the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) by AveThera GmbH, effective March 16, 2026, as an important step for the region and particularly for the Science Campus Braunschweig-Süd. Core competencies in pharmaceutical biotechnology will remain in Braunschweig, while the Science Campus will be further strengthened as a center for the development and manufacturing of modern biopharmaceutical products.

16.03.2026

HZI Campus

Microscopic image of cells with blue cell nuclei and green and magenta-colored structures

News

An interdisciplinary consortium consisting of TWINCORE, Centre for Experimental and Clinical Infection Research, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, the University of Lübeck and Hannover Medical School (MHH), is receiving funding of around €999,000 from the Volkswagen Foundation. Under the leadership of Prof. Thomas Pietschmann, the team plans to optimize active substances against the respiratory syncytial virus (RSV) over the next two years. TWINCORE and HIPS are sites of the HZI in collaboration with MHH and Saarland University, respectively.

13.03.2026

TWINCORE

HIPS

HZI Campus

Groupphoto of Rainer Waldschmidt, Aditya Shekhar, Dominik Heimann, Stefan Bartoschek

News

The Science4Life Startup Competition supports teams of founders from the life sciences, chemistry, and energy sectors in transforming their excellent scientific ideas into marketable innovations. In the latest concept phase, the team behind the “PROTON” project from the Helmholtz Centre for Infection Research (HZI) was named the winner. PROTON is developing a novel active substance for the treatment of infections caused by the bacterium Staphylococcus aureus. Of the 91 applications for the concept phase of the Science4Life Venture Cup, the organizers invited ten teams to present their concepts. Ultimately, they selected five winning teams from the fields of life sciences and chemistry, as well as one team from the field of energy research.

12.03.2026

HZI Campus

Rolf Müller and Katharina Schaufler Portrait collage

News

Two researchers from the Helmholtz Centre for Infection Research (HZI) serve as advisors to a European consortium working to combat antimicrobial resistance. Prof. Rolf Müller, Scientific Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and Head of the Research Unit “Novel Antibiotics” at the German Center for Infection Research (DZIF), and Prof. Katharina Schaufler, Head of the Department “Epidemiology and ecology of antimicrobial resistance” at the Helmholtz Institute for One Health, have been appointed to the Scientific Advisory Board of the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR). HIPS and HIOH are sites of the HZI in collaboration with Saarland University and partner institutions in Greifswald, respectively.

12.03.2026

HIPS

HIOH

Symbolic image of a baby in a bubble made of technical particles

News

Maternal health during pregnancy plays a critical role in shaping the long-term health of her child. Researchers at the Helmholtz Centre for Infection Research (HZI), together with partners at the Hebrew University of Jerusalem, are investigating how maternal inflammatory conditions influence immune development in newborns. The project focuses on immune cells in the oral and intestinal mucosa, key tissues that form the body’s first line of defense against pathogens. The researchers aim to understand how these immune compartments are shaped early in life and how this may influence the child’s susceptibility to infections, inflammatory diseases, and vaccine responses later in life.

09.03.2026

HZI Campus

[Translate to English:] Getrocknetes Salz und Mukus in Atemflüssigkeit

News

When viruses infect the respiratory tract, they first come into contact with a viscous gel called mucus. Only viruses that can overcome this layer on the cells of the mucous membranes are able to infect a host. In the joint project ONEMUC, which is funded by the German Federal Ministry of Research, Technology and Space (BMFTR) with 4.3 million euros, researchers at the Helmholtz Centre for Infection Research (HZI) and cooperation partners are investigating the role of mucus as a barrier in the transmission of zoonotic influenza A viruses. At the HZI, group leaders Prof. Christian Sieben and Dr Julia Port are investigating how mucus and environmental factors influence virus transmission. The five-year project started on March 1, 2026.

03.03.2026

HZI Campus

HZI in the media

Vorsorge Das Coronavirus hält die Welt nicht mehr in Atem. Doch was, wenn ein anderer gefährlicher Erreger auftaucht? So wappnet sich unser Gesundheitssystem

16.03.2026

Apotheken Umschau

... stumpfen ab“, erklärt Marc Brönstrup vom Helmholtz-Zentrum für Infektionsforschung in Braunschweig. Neue Antibiotika sind dringend ...

14.03.2026

ARD Mediathek

... der Medizinischen Hochschule Hannover und dem Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig neue Wirkstoffe ...

13.03.2026

MTA Dialog

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026

DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026

Biermann Medizin

Mdisk, stock.adobe.com

Braunschweig – Das Helmholtz-Zentrum für Infektionsforschung ( HZI ) in Braunschweig erhält für sein ...

03.03.2026

Deutsches Ärzteblatt

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz Zentrums für Infektionsforschung in Braunschweig und Professor für

01.03.2026

EUROPE SAYS

... Körperzellen. Damit tragen wir, wie das Helmholtz-Zentrum für Infektionsforschung (HZI) es treffend beschreibt, unseren „ganz ...

27.02.2026

MSN Deutschland

Eine Impfung bringt das Immunsystem in Stellung, bevor der echte Erreger kommt. Erfahren Sie, wie ...

26.02.2026

Apotheken Umschau

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.